Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases

Chemistry and Physics of Lipids

Volumn 197, Issue , 2016, Pages 45-59

  Adada, Mohamad ^a   Luberto, Chiara ^a   Canals, Daniel ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Ceramide; Sphingolipids; Sphingomyelin; Sphingomyelinase; Sphingomyelinase synthase

Indexed keywords

3,3' (1,4 PHENYLENE)BIS[N [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ACRYLAMIDE]; ALKALINE SPHINGOMYELINASE; C 11AG; CERAMIDE; DOFEQUIDAR; ENZYME INHIBITOR; FANTOFARONE; FINGOLIMOD; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; SCYPHOSTATIN; SIRAMESINE; SMA 7; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINASE SYNTHASE; SPHINGOSINE; SYNTHETASE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; PHOSPHATIDYLCHOLINE-CERAMIDE PHOSPHOCHOLINE TRANSFERASE; PHOSPHOTRANSFERASE;

CELLULAR DISTRIBUTION; EMPHYSEMA; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION; HUMAN; HYDROLYSIS; METASTASIS; MOLECULAR PATHOLOGY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; METABOLISM;

ANIMALS; ENZYME INHIBITORS; HUMANS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 84960801135     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2015.07.008     Document Type: Review

References (186)

1. A. Abe, J.A. Shayman, and N.S. Radin A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides J. Biol. Chem. 271 1996 14383 14389
2. M. Adada, D. Canals, Y.A. Hannun, and L.M. Obeid Sphingosine-1-phosphate receptor 2 FEBS J. 280 2013 6354 6366
3. M. Adada, D. Canals, Y.A. Hannun, and L.M. Obeid Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics Biochim. Biophys. Acta 1841 2014 727 737
4. S. Aits, and M. Jaattela Lysosomal cell death at a glance J. Cell Sci. 126 2013 1905 1912
5. S. Albouz, J.J. Hauw, Y. Berwald-Netter, J.M. Boutry, R. Bourdon, and N. Baumann Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures Biomedicine 35 1981 218 220
6. E. Amtmann, W. Baader, and M. Zoller Neutral sphingomyelinase inhibitor C11AG prevents lipopolysaccharide-induced macrophage activation Drugs Exp. Clin. Res. 29 2003 5 13
7. E. Amtmann, K. Muller-Decker, A. Hoss, G. Schalasta, C. Doppler, and G. Sauer Synergistic antiviral effect of xanthates and ionic detergents Biochem. Pharmacol. 36 1987 1545 1549
8. E. Amtmann, and M. Zoller Stimulation of CD95-induced apoptosis in T-cells by a subtype specific neutral sphingomyelinase inhibitor Biochem. Pharmacol. 69 2005 1141 1148
9. E. Amtmann, M. Zoller, and G. Schilling Neutral sphingomyelinase-inhibiting guanidines prevent herpes simplex virus-1 replication Drugs Exp. Clin. Res. 26 2000 57 65
10. L. Arana, M. Ordonez, A. Ouro, I.G. Rivera, P. Gangoiti, M. Trueba, and A. Gomez-Munoz Ceramide 1-phosphate induces macrophage chemoattractant protein-1 release: involvement in ceramide 1-phosphate-stimulated cell migration Am. J. Physiol. Endocrinol. Metab. 304 2013 E1213 E1226
11. C. Arenz, M. Gartner, V. Wascholowski, and A. Giannis Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase Bioorg. Med. Chem. 9 2001 2901 2904
12. K. Ayasolla, M. Khan, A.K. Singh, and I. Singh Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E Free Radic. Biol. Med. 37 2004 325 338
13. M. Baba, O. Nakanishi, W. Sato, A. Saito, Y. Miyama, O. Yano, S. Shimada, N. Fukazawa, M. Naito, and T. Tsuruo Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells Cancer Chemother. Pharmacol. 36 1995 361 367
14. R. Barsacchi, C. Perrotta, S. Bulotta, S. Moncada, N. Borgese, and E. Clementi Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3′ kinase, and Akt Mol. Pharmacol. 63 2003 886 895
15. K.P. Becker, K. Kitatani, J. Idkowiak-Baldys, J. Bielawski, and Y.A. Hannun Selective inhibition of juxtanuclear translocation of protein kinase C betaII by a negative feedback mechanism involving ceramide formed from the salvage pathway J. Biol. Chem. 280 2005 2606 2612
16. C. Belka, K. Wiegmann, D. Adam, R. Holland, M. Neuloh, F. Herrmann, M. Kronke, and M.A. Brach Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase EMBO J. 14 1995 1156 1165
17. H. Birbes, S. El Bawab, Y.A. Hannun, and L.M. Obeid Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis FASEB J. 15 2001 2669 2679
18. A. Butler, He, X. Gordon, R.E. Wu, H.S. Gatt, S. Schuchman, and EH Reproductive pathology and sperm physiology in acid sphingomyelinase-deficient mice Am. J. Pathol. 161 2002 1061 1075
19. D. Canals, and Y.A. Hannun Novel chemotherapeutic drugs in sphingolipid cancer research Handb. Exp. Pharmacol. 2013 211 238
20. D. Canals, R.W. Jenkins, P. Roddy, M.J. Hernandez-Corbacho, L.M. Obeid, and Y.A. Hannun Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane J. Biol. Chem. 285 2010 32476 32485
21. A. Carpinteiro, K.A. Becker, L. Japtok, G. Hessler, S. Keitsch, M. Pozgajova, K.W. Schmid, C. Adams, S. Muller, B. Kleuser, M.J. Edwards, H. Grassme, I. Helfrich, and E. Gulbins Regulation of hematogenous tumor metastasis by acid sphingomyelinase EMBO Mol. Med. 2015
22. A.C. Carreira, A.E. Ventura, A.R. Varela, and L.C. Silva Tackling the biophysical properties of sphingolipids to decipher their biological roles Biol. Chem. 2015
23. A. Chairoungdua, D.L. Smith, P. Pochard, M. Hull, and M.J. Caplan Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling J. Cell Biol. 190 2010 1079 1091
24. A. Charruyer, C. Jean, A. Colomba, J.P. Jaffrezou, A. Quillet-Mary, G. Laurent, and C. Bezombes PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide production Biochem. J. 405 2007 77 83
25. Y. Chen, P. Zhang, S.C. Xu, L. Yang, U. Voss, E. Ekblad, Y. Wu, Y. Min, E. Hertervig, A. Nilsson, and R.D. Duan Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice Mol. Cancer Ther. 14 2015 259 267
26. N.U. Chi le, K. Tabuchi, M. Nakamagoe, M. Nakayama, B. Nishimura, and A. Hara Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death Arch. Toxicol. 89 2015 415 421
27. C.J. Clarke, K. Mediwala, R.W. Jenkins, C.A. Sutton, B.G. Tholanikunnel, and Y.A. Hannun Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase J. Biol. Chem. 286 2011 21565 21576
28. C.J. Clarke, C.F. Snook, M. Tani, N. Matmati, N. Marchesini, and Y.A. Hannun The extended family of neutral sphingomyelinases Biochemistry 45 2006 11247 11256
29. C.A. Corcoran, Q. He, S. Ponnusamy, B. Ogretmen, Y. Huang, and M.S. Sheikh Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies Mol. Cancer Res. 6 2008 795 807
30. G. Dawson, and J. Qin Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants Biochem. Biophys. Res. Commun. 404 2011 321 323
31. C. De Palma, E. Meacci, C. Perrotta, P. Bruni, and E. Clementi Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium Arterioscler. Thromb. Vasc. Biol. 26 2006 99 105
32. G.M. Deevska, K.A. Rozenova, N.V. Giltiay, M.A. Chambers, J. White, B.B. Boyanovsky, J. Wei, A. Daugherty, E.J. Smart, M.B. Reid, A.H. Merrill Jr., and M. Nikolova-Karakashian Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice J. Biol. Chem. 284 2009 8359 8368
33. G.M. Deevska, M. Sunkara, A.J. Morris, and M.N. Nikolova-Karakashian Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet Biosci. Rep. 32 2012 479 490
34. A. Delgado, J. Casas, A. Llebaria, J.L. Abad, and G. Fabrias Inhibitors of sphingolipid metabolism enzymes Biochim. Biophys. Acta 1758 2006 1957 1977
35. X. Deng, F. Lin, Y. Zhang, Y. Li, L. Zhou, B. Lou, Y. Li, J. Dong, T. Ding, X. Jiang, R. Wang, and D. Ye Identification of small molecule sphingomyelin synthase inhibitors Eur. J. Med. Chem. 73 2014 1 7
36. R. Dhami, He, X. Schuchman, and EH Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice Cell. Physiol. Biochem. 26 2010 749 760
37. D.L. Dillehay, S.K. Webb, E.M. Schmelz, and A.H. Merrill Jr. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice J. Nutr. 124 1994 615 620
38. T. Ding, Z. Li, T. Hailemariam, S. Mukherjee, F.R. Maxfield, M.P. Wu, and X.C. Jiang SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis J. Lipid Res. 49 2008 376 385
39. M.B. Dinkins, S. Dasgupta, G. Wang, G. Zhu, and E. Bieberich Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease Neurobiol. Aging 35 2014 1792 1800
40. H. Diringer, and M.A. Koch Biosynthesis of sphingomyelin. Transfer of phosphorylcholine from phosphatidylcholine to erythro-ceramide in a cell-free system Hoppe Seylers Z. Physiol. Chem. 354 1973 1661 1665
41. J. Dong, J. Liu, B. Lou, Z. Li, X. Ye, M. Wu, and X.C. Jiang Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice J. Lipid Res. 47 2006 1307 1314
42. L. Dong, K. Watanabe, M. Itoh, C.R. Huan, X.P. Tong, T. Nakamura, M. Miki, H. Iwao, A. Nakajima, T. Sakai, T. Kawanami, T. Sawaki, Y. Masaki, T. Fukushima, Y. Fujita, M. Tanaka, M. Yano, T. Okazaki, and H. Umehara CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice Int. Immunol. 24 2012 327 337
43. S. Dreschers, P. Franz, C. Dumitru, B. Wilker, K. Jahnke, and E. Gulbins Infections with human rhinovirus induce the formation of distinct functional membrane domains Cell. Physiol. Biochem. 20 2007 241 254
44. R.D. Duan, T. Bergman, N. Xu, J. Wu, Y. Cheng, J. Duan, S. Nelander, C. Palmberg, and A. Nilsson Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family J. Biol. Chem. 278 2003 38528 38536
45. R.D. Duan, E. Hertervig, L. Nyberg, T. Hauge, B. Sternby, J. Lillienau, A. Farooqi, and A. Nilsson Distribution of alkaline sphingomyelinase activity in human beings and animals Tissue and species differences Dig. Dis. Sci. 41 1996 1801 1806
46. H.M. Empinado, G.M. Deevska, M. Nikolova-Karakashian, J.K. Yoo, D.D. Christou, and L.F. Ferreira Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content Eur. J. Heart Fail. 16 2014 519 525
47. D. Ernst, S.M. Murphy, K. Sathiyanadan, Y. Wei, A. Othman, M. Laura, Y.T. Liu, A. Penno, J. Blake, M. Donaghy, H. Houlden, M.M. Reilly, and T. Hornemann Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity Neuromol. Med. 17 2015 47 57
48. G. Fabrias, J. Munoz-Olaya, F. Cingolani, P. Signorelli, J. Casas, V. Gagliostro, and R. Ghidoni Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena Prog. Lipid Res. 51 2012 82 94
49. Y. Fan, F. Shi, J. Liu, J. Dong, H.H. Bui, D.A. Peake, M.S. Kuo, G. Cao, and X.C. Jiang Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 30 2010 2114 2120
50. H.A. Favre, and W.H. Powell Nomenclature of Organic Chemistry 2013 IUPAC Recommendations and Preferred Names
51. A. Fernandez, N. Matias, R. Fucho, V. Ribas, C. Von Montfort, N. Nuno, A. Baulies, L. Martinez, N. Tarrats, M. Mari, A. Colell, A. Morales, L. Dubuquoy, P. Mathurin, R. Bataller, J. Caballeria, M. Elena, J. Balsinde, N. Kaplowitz, C. Garcia-Ruiz, and J.C. Fernandez-Checa ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading J. Hepatol. 59 2013 805 813
52. N.S. Ferreira, M. Goldschmidt-Arzi, H. Sabanay, J. Storch, T. Levade, M.G. Ribeiro, L. Addadi, and A.H. Futerman Accumulation of ordered ceramide-cholesterol domains in farber disease fibroblasts JIMD Rep. 12 2014 71 77
53. S. Filosto, M. Ashfaq, S. Chung, W. Fry, and T. Goldkorn Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines J. Biol. Chem. 287 2012 514 522
54. J. Folch, I. Ascoli, M. Lees, J.A. Meath, and B.N. Le Preparation of lipide extracts from brain tissue J. Biol. Chem. 191 1951 833 841
55. M. Garcia-Barros, D. Lacorazza, H. Petrie, A. Haimovitz-Friedman, C. Cardon-Cardo, S. Nimer, Z. Fuks, and R. Kolesnick Host acid sphingomyelinase regulates microvascular function not tumor immunity Cancer Res. 64 2004 8285 8291
56. F.M. Goni, and A. Alonso Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids Biochim. Biophys. Acta 1758 2006 1902 1921
57. A. Gonzalez-Roura, J. Casas, and A. Llebaria Synthesis and phospholipase C inhibitory activity of D609 diastereomers Lipids 37 2002 401 406
58. V. Gouaze-Andersson, M. Flowers, R. Karimi, G. Fabrias, A. Delgado, J. Casas, and M.C. Cabot Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide Prostate 71 2011 1064 1073
59. S. Gowda, C. Yeang, S. Wadgaonkar, F. Anjum, N. Grinkina, M. Cutaia, X.C. Jiang, and R. Wadgaonkar Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injury Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2011 L430 L440
60. H. Grassme, V. Jendrossek, A. Riehle, G. von Kurthy, J. Berger, H. Schwarz, M. Weller, R. Kolesnick, and E. Gulbins Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts Nat. Med. 9 2003 322 330
61. H. Grassme, A. Riehle, B. Wilker, and E. Gulbins Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms J. Biol. Chem. 280 2005 26256 26262
62. J.R. Guyton, and K.F. Klemp Development of the lipid-rich core in human atherosclerosis Arterioscler. Thromb. Vasc. Biol. 16 1996 4 11
63. T.K. Hailemariam, C. Huan, J. Liu, Z. Li, C. Roman, M. Kalbfeisch, H.H. Bui, D.A. Peake, M.S. Kuo, G. Cao, R. Wadgaonkar, and X.C. Jiang Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation Arterioscler. Thromb. Vasc. Biol. 28 2008 1519 1526
64. Y.A. Hannun, C.R. Loomis, A.H. Merrill Jr., and R.M. Bell Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets J. Biol. Chem. 261 1986 12604 12609
65. Y.A. Hannun, and B. Newcomb A new twist to the emerging functions of ceramides in: novel role for platelet acid sphingomyelinase in cancer metastasis EMBO Mol. Med. 2015
66. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat. Rev. Mol. Cell Biol. 9 2008 139 150
67. Y.A. Hannun, and L.M. Obeid Many ceramides J. Biol. Chem. 286 2011 27855 27862
68. E. Hertervig, A. Nilsson, L. Nyberg, and R.D. Duan Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma Cancer 79 1997 448 453
69. K. Hofmann, S. Tomiuk, G. Wolff, and W. Stoffel Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase Proc. Natl. Acad. Sci. U. S. A. 97 2000 5895 5900
70. M.R. Hojjati, Z. Li, H. Zhou, S. Tang, C. Huan, E. Ooi, S. Lu, and X.C. Jiang Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice J. Biol. Chem. 280 2005 10284 10289
71. J.C. Holthuis, and C. Luberto Tales and mysteries of the enigmatic sphingomyelin synthase family Adv. Exp. Med. Biol. 688 2010 72 85
72. K. Horinouchi, S. Erlich, D.P. Perl, K. Ferlinz, C.L. Bisgaier, K. Sandhoff, R.J. Desnick, C.L. Stewart, and E.H. Schuchman Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease Nat. Genet. 10 1995 288 293
73. K. Huitema, J. van den Dikkenberg, J.F. Brouwers, and J.C. Holthuis Identification of a family of animal sphingomyelin synthases EMBO J. 23 2004 33 44
74. J.P. Jaffrezou, J.M. Herber, T. Levade, M.N. Gau, P. Chatelain, and G. Laurent Reversal of multidrug resistance by calcium channel blocker SR. 33. 557 without photoaffinity labeling of P-glycoprotein J. Biol. Chem. 266 19 1991 858 19864
75. A. Jana, and K. Pahan Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis J. Neuroimmune Pharmacol. 2 2007 184 193
76. S. Jayadev, C.M. Linardic, and Y.A. Hannun Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha J. Biol. Chem. 269 1994 5757 5763
77. R.W. Jenkins, D. Canals, and Y.A. Hannun Roles and regulation of secretory and lysosomal acid sphingomyelinase Cell Signal. 21 2009 836 846
78. R.W. Jenkins, D. Canals, J. Idkowiak-Baldys, F. Simbari, P. Roddy, D.M. Perry, K. Kitatani, C. Luberto, and Y.A. Hannun Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation J. Biol. Chem. 285 2010 35706 35718
79. R.W. Jenkins, J. Idkowiak-Baldys, F. Simbari, D. Canals, P. Roddy, C.D. Riner, C.J. Clarke, and Y.A. Hannun A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing J. Biol. Chem. 286 2011 3777 3788
80. J. Jin, X. Zhang, Z. Lu, D.M. Perry, Y. Li, S.B. Russo, L.A. Cowart, Y.A. Hannun, and Y. Huang Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages Am. J. Physiol. Endocrinol. Metab. 305 2013 E853 E867
81. Z.X. Jin, C.R. Huang, L. Dong, S. Goda, T. Kawanami, T. Sawaki, T. Sakai, X.P. Tong, Y. Masaki, T. Fukushima, M. Tanaka, T. Mimori, H. Tojo, E.T. Bloom, T. Okazaki, and H. Umehara Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells Int. Immunol. 20 2008 1427 1437
82. H. Kakoi, S. Maeda, N. Shinohara, K. Matsuyama, K. Imamura, I. Kawamura, S. Nagano, T. Setoguchi, M. Yokouchi, Y. Ishidou, and S. Komiya Bone morphogenic protein (BMP) signaling up-regulates neutral sphingomyelinase 2 to suppress chondrocyte maturation via the Akt protein signaling pathway as a negative feedback mechanism J. Biol. Chem. 289 2014 8135 8150
83. J.N. Kanfer, O.M. Young, D. Shapiro, and R.O. Brady The metabolism of sphingomyelin. I. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue J. Biol. Chem. 241 1966 1081 1084
84. Z. Khavandgar, C. Poirier, C.J. Clarke, J. Li, N. Wang, M.D. McKee, Y.A. Hannun, and M. Murshed A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization J. Cell Biol. 194 2011 277 289
85. T. Kirkegaard, A.G. Roth, N.H. Petersen, A.K. Mahalka, O.D. Olsen, I. Moilanen, A. Zylicz, J. Knudsen, K. Sandhoff, C. Arenz, P.K. Kinnunen, J. Nylandsted, and M. Jaattela Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology Nature 463 2010 549 553
86. A. Kolmakova, P. Kwiterovich, D. Virgil, P. Alaupovic, C. Knight-Gibson, S.F. Martin, and S. Chatterjee Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase Arterioscler. Thromb. Vasc. Biol. 24 2004 264 269
87. J.N. Kong, Q. He, G. Wang, S. Dasgupta, M.B. Dinkins, G. Zhu, A. Kim, S. Spassieva, and E. Bieberich Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB -231 cells Int. J. Cancer 2015
88. A. Kontush, M. Lhomme, and M.J. Chapman Unraveling the complexities of the HDL lipidome J. Lipid Res. 54 2013 2950 2963
89. N. Kosaka, H. Iguchi, K. Hagiwara, Y. Yoshioka, F. Takeshita, and T. Ochiya Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis J. Biol. Chem. 288 2013 10849 10859
90. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya Secretory mechanisms and intercellular transfer of microRNAs in living cells J. Biol. Chem. 285 2010 17442 17452
91. O. Krut, K. Wiegmann, H. Kashkar, B. Yazdanpanah, and M. Kronke Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein J. Biol. Chem. 281 2006 13784 13793
92. Y. Li, J. Dong, T. Ding, M.S. Kuo, G. Cao, X.C. Jiang, and Z. Li Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor gamma2 suppression Arterioscler. Thromb. Vasc. Biol. 33 2013 1513 1520
93. Z. Li, Y. Fan, J. Liu, Y. Li, C. Huan, H.H. Bui, M.S. Kuo, T.S. Park, G. Cao, and X.C. Jiang Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice Arterioscler. Thromb. Vasc. Biol. 32 2012 1577 1584
94. Z. Li, T.K. Hailemariam, H. Zhou, Y. Li, D.C. Duckworth, D.A. Peake, Y. Zhang, M.S. Kuo, G. Cao, and X.C. Jiang Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization Biochim. Biophys. Acta 1771 2007 1186 1194
95. Z. Li, H. Zhang, J. Liu, C.P. Liang, Y. Li, Y. Li, G. Teitelman, T. Beyer, H.H. Bui, D.A. Peake, Y. Zhang, P.E. Sanders, M.S. Kuo, T.S. Park, G. Cao, and X.C. Jiang Reducing plasma membrane sphingomyelin increases insulin sensitivity Mol. Cell Biol. 31 2011 4205 4218
96. D. Lingwood, H.J. Kaiser, I. Levental, and K. Simons Lipid rafts as functional heterogeneity in cell membranes Biochem. Soc. Trans. 37 2009 955 960
97. M.D. Lister, C.L. Crawford-Redick, and C.R. Loomis Characterization of the neutral pH-optimum sphingomyelinase from rat brain: inhibition by copper II and ganglioside GM3 Biochim. Biophys. Acta 1165 1993 314 320
98. B. Liu, and Y.A. Hannun Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione J. Biol. Chem. 272 1997 16281 16287
99. B. Liu, D.F. Hassler, G.K. Smith, K. Weaver, and Y.A. Hannun Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain J. Biol. Chem. 273 1998 34472 34479
100. J. Liu, and D.Y. Stainier Zebrafish in the study of early cardiac development Circ. Res. 110 2012 870 874
101. J. Liu, H. Zhang, Z. Li, T.K. Hailemariam, M. Chakraborty, K. Jiang, D. Qiu, H.H. Bui, D.A. Peake, M.S. Kuo, R. Wadgaonkar, G. Cao, and X.C. Jiang Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice Arterioscler. Thromb. Vasc. Biol. 29 2009 850 856
102. A.M. Lopez, S.J. Terpack, K.S. Posey, B. Liu, C.M. Ramirez, and S.D. Turley Systemic administration of 2-hydroxypropyl-beta-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function Clin. Exp. Pharmacol. Physiol. 41 2014 780 787
103. B. Lou, J. Dong, Y. Li, T. Ding, T. Bi, Y. Li, X. Deng, D. Ye, and X.C. Jiang Pharmacologic inhibition of sphingomyelin synthase (SMS) activity reduces apolipoprotein-B secretion from hepatocytes and attenuates endotoxin-mediated macrophage inflammation PLoS One 9 2014 e102641
104. M.H. Lu, M. Takemoto, K. Watanabe, H. Luo, M. Nishimura, M. Yano, H. Tomimoto, T. Okazaki, Y. Oike, and W.J. Song Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice J. Physiol. 590 2012 4029 4044
105. C. Luberto, and Y.A. Hannun Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J. Biol. Chem. 273 1998 14550 14559
106. C. Luberto, D.F. Hassler, P. Signorelli, Y. Okamoto, H. Sawai, E. Boros, D.J. Hazen-Martin, L.M. Obeid, Y.A. Hannun, and G.K. Smith Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase J. Biol. Chem. 277 2002 41128 41139
107. C. Luberto, J.M. Kraveka, and Y.A. Hannun Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology Neurochem. Res. 27 2002 609 617
108. S. Marathe, S.L. Schissel, M.J. Yellin, N. Beatini, R. Mintzer, K.J. Williams, and I. Tabas Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling J. Biol. Chem. 273 1998 4081 4088
109. N. Marchesini, C. Luberto, and Y.A. Hannun Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism J. Biol. Chem. 278 2003 13775 13783
110. N. Marchesini, W. Osta, J. Bielawski, C. Luberto, L.M. Obeid, and Y.A. Hannun Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells J. Biol. Chem. 279 2004 25101 25111
111. M. Masson, S. Albouz, J.M. Boutry, B. Spezzatti, M. Castagna, and N. Baumann Calmodulin antagonist W-7 inhibits lysosomal sphingomyelinase activity in C6 glioma cells J. Neurochem. 52 1989 1645 1647
112. A.H. Merrill Jr. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics Chem. Rev. 111 2011 6387 6422
113. M.A. Mikati, M. Zeinieh, R.A. Habib, J. El Hokayem, A. Rahmeh, M. El Sabban, J. Usta, and G. Dbaibo Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus Epilepsy Res. 81 2008 161 166
114. S. Mitsutake, K. Zama, H. Yokota, T. Yoshida, M. Tanaka, M. Mitsui, M. Ikawa, M. Okabe, Y. Tanaka, T. Yamashita, H. Takemoto, T. Okazaki, K. Watanabe, and Y. Igarashi Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes J. Biol. Chem. 286 2011 28544 28555
115. M. Mittelbrunn, C. Gutierrez-Vazquez, C. Villarroya-Beltri, S. Gonzalez, F. Sanchez-Cabo, M.A. Gonzalez, A. Bernad, and F. Sanchez-Madrid Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells Nat. Commun. 2 2011 282
116. M. Miyaji, Z.X. Jin, S. Yamaoka, R. Amakawa, S. Fukuhara, S.B. Sato, T. Kobayashi, N. Domae, T. Mimori, E.T. Bloom, T. Okazaki, and H. Umehara Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis J. Exp. Med. 202 2005 249 259
117. J.S. Moylan, J.D. Smith, E.M. Wolf Horrell, J.B. McLean, G.M. Deevska, M.R. Bonnell, M.N. Nikolova-Karakashian, and M.B. Reid Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle Redox Biol. 2 2014 910 920
118. T.D. Mullen, Y.A. Hannun, and L.M. Obeid Ceramide synthases at the centre of sphingolipid metabolism and biology Biochem. J. 441 2012 789 802
119. K. Muller-Decker Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction Biochem. Biophys. Res. Commun. 162 1989 198 205
120. T. Nakamura, M. Oka, K. Aizawa, H. Soda, M. Fukuda, K. Terashi, K. Ikeda, Y. Mizuta, Y. Noguchi, Y. Kimura, T. Tsuruo, and S. Kohno Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells Biochem. Biophys. Res. Commun. 255 1999 618 624
121. F. Nara, M. Tanaka, T. Hosoya, K. Suzuki-Konagai, and T. Ogita Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties J. Antibiot. (Tokyo) 52 1999 525 530
122. F. Nara, M. Tanaka, S. Masuda-Inoue, Y. Yamasato, H. Doi-Yoshioka, K. Suzuki-Konagai, S. Kumakura, and T. Ogita Biological activities of scyphostatin a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima J. Antibiot. (Tokyo) 52 1999 531 535
123. M.C. Nassogne, C. Lizarraga, F. N'Kuli, F. Van Bambeke, R. Van Binst, P. Wallemacq, P.M. Tulkens, M.P. Mingeot-Leclercq, T. Levade, and P.J. Courtoy Cocaine induces a mixed lysosomal lipidosis in cultured fibroblasts, by inactivation of acid sphingomyelinase and inhibition of phospholipase A1 Toxicol. Appl. Pharmacol. 194 2004 101 110
124. D. Newrzella, and W. Stoffel Functional analysis of the glycosylation of murine acid sphingomyelinase J. Biol. Chem. 271 1996 32089 32095
125. H. Nokihara, S. Yano, Y. Nishioka, M. Hanibuchi, T. Higasida, T. Tsuruo, and S. Sone A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells Jpn. J. Cancer Res. 92 2001 785 792
126. S.A. Novgorodov, B.X. Wu, T.I. Gudz, J. Bielawski, T.V. Ovchinnikova, Y.A. Hannun, and L.M. Obeid Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA J. Biol. Chem. 286 2011 25352 25362
127. L. Nyberg, R.D. Duan, J. Axelson, and A. Nilsson Identification of an alkaline sphingomyelinase activity in human bile Biochim. Biophys. Acta 1300 1996 42 48
128. N.W. O'Brien, N.M. Gellings, M. Guo, S.B. Barlow, C.C. Glembotski, and R.A. Sabbadini Factor associated with neutral sphingomyelinase activation and its role in cardiac cell death Circ. Res. 92 2003 589 591
129. L.M. Obeid, C.M. Linardic, L.A. Karolak, and Y.A. Hannun Programmed cell death induced by ceramide Science 259 1993 1769 1771
130. T. Okazaki, R.M. Bell, and Y.A. Hannun Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation J. Biol. Chem. 264 1989 19076 19080
131. V.O. Oninla, B. Breiden, J.O. Babalola, and K. Sandhoff Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2 J. Lipid Res. 55 2014 2606 2619
132. B. Otterbach, and W. Stoffel Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease) Cell 81 1995 1053 1061
133. M. Pascual, S.L. Valles, J. Renau-Piqueras, and C. Guerri Ceramide pathways modulate ethanol-induced cell death in astrocytes J. Neurochem. 87 2003 1535 1545
134. A.L. Pearson A comparison between the molecular weights of protagon and of the phosphatide and cerebrosides obtainable from it Biochem. J. 8 1914 616 627
135. A. Penno, M.M. Reilly, H. Houlden, M. Laura, K. Rentsch, V. Niederkofler, E.T. Stoeckli, G. Nicholson, F. Eichler, R.H. Brown Jr., A. von Eckardstein, and T. Hornemann Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids J. Biol. Chem. 285 2010 11178 11187
136. R.J. Perry, and N.D. Ridgway The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609 J. Lipid Res. 45 2004 164 173
137. N.H. Petersen, O.D. Olsen, L. Groth-Pedersen, A.M. Ellegaard, M. Bilgin, S. Redmer, M.S. Ostenfeld, D. Ulanet, T.H. Dovmark, A. Lonborg, S.D. Vindelov, D. Hanahan, C. Arenz, C.S. Ejsing, T. Kirkegaard, M. Rohde, J. Nylandsted, and M. Jaattela Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase Cancer Cell 24 2013 379 393
138. C. Poirier, E.V. Berdyshev, C. Dimitropoulou, N.V. Bogatcheva, P.W. Biddinger, and A.D. Verin Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema Mamm. Genome 23 2012 758 763
139. S.M. Pontier, and F. Schweisguth Glycosphingolipids in signaling and development: from liposomes to model organisms Dev. Dyn. 241 2012 92 106
140. C.P. Ponting Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D Protein Sci. 3 1994 359 361
141. D. Pozo, M. Vales-Gomez, N. Mavaddat, S.C. Williamson, S.E. Chisholm, and H. Reyburn CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase J. Immunol. 176 2006 2397 2406
142. J. Qin, E. Berdyshev, C. Poirer, N.B. Schwartz, and G. Dawson Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt J. Biol. Chem. 287 2012 13620 13632
143. J. Qin, F.D. Testai, S. Dawson, J. Kilkus, and G. Dawson Oxidized phosphatidylcholine formation and action in oligodendrocytes J. Neurochem. 110 2009 1388 1399
144. L.E. Quintern, and K. Sandhoff Human acid sphingomyelinase from human urine Methods Enzymol. 197 1991 536 540
145. L.E. Quintern, T.S. Zenk, and K. Sandhoff The urine from patients with peritonitis as a rich source for purifying human acid sphingomyelinase and other lysosomal enzymes Biochim. Biophys. Acta 1003 1989 121 124
146. V. Rajagopalan, D. Canals, C. Luberto, J. Snider, C. Voelkel-Johnson, L.M. Obeid, and Y.A. Hannun Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization Biochim. Biophys. Acta 1850 2015 628 639
147. A. Rebillard, N. Rioux-Leclercq, C. Muller, P. Bellaud, F. Jouan, O. Meurette, E. Jouan, L. Vernhet, C. Le Quement, A. Carpinteiro, M. Schenck, D. Lagadic-Gossmann, E. Gulbins, and M.T. Dimanche-Boitrel Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage Oncogene 27 2008 6590 6595
148. A. Sakata, K. Yasuda, T. Ochiai, H. Shimeno, S. Hikishima, T. Yokomatsu, S. Shibuya, and S. Soeda Inhibition of lipopolysaccharide-induced release of interleukin-8 from intestinal epithelial cells by SMA, a novel inhibitor of sphingomyelinase and its therapeutic effect on dextran sulphate sodium-induced colitis in mice Cell Immunol. 245 2007 24 31
149. R. Savic, He, X. Fiel, I. Schuchman, and EH Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer PLoS One 8 2013 e65620
150. R. Savic, and E.H. Schuchman Use of acid sphingomyelinase for cancer therapy Adv. Cancer Res. 117 2013 91 115
151. H. Sawai, N. Domae, N. Nagan, and Y.A. Hannun Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C J. Biol. Chem. 274 1999 38131 38139
152. P.B. Schneider, and E.P. Kennedy Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease J. Lipid Res. 8 1967 202 209
153. E.H. Schuchman Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease FEBS Lett. 584 2010 1895 1900
154. E.H. Schuchman, O. Levran, L.V. Pereira, and R.J. Desnick Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1) Genomics 12 1992 197 205
155. E.H. Schuchman, M. Suchi, T. Takahashi, K. Sandhoff, and R.J. Desnick Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs J. Biol. Chem. 266 1991 8531 8539
156. A.A. Shamseddine, M.V. Airola, and Y.A. Hannun Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes Adv. Biol. Regul. 57 2015 24 41
157. C.M. Simonaro, J.H. Park, E. Eliyahu, N. Shtraizent, M.M. McGovern, and E.H. Schuchman Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease Am. J. Hum. Genet. 78 2006 865 870
158. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
159. E.L. Smith, and E.H. Schuchman The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases FASEB J. 22 2008 3419 3431
160. S. Spassieva, and E. Bieberich The gut-to-breast connection - interdependence of sterols and sphingolipids in multidrug resistance and breast cancer therapy Anticancer Agents Med. Chem. 11 2011 882 890
161. W. Stoffel, B. Jenke, B. Block, M. Zumbansen, and J. Koebke Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development Proc. Natl. Acad. Sci. U. S. A. 102 2005 4554 4559
162. M. Tanaka, F. Nara, Y. Yamasato, S. Masuda-Inoue, H. Doi-Yoshioka, S. Kumakura, R. Enokita, and T. Ogita Macquarimicin A inhibits membrane-bound neutral sphingomyelinase from rat brain J. Antibiot. (Tokyo) 52 1999 670 673
163. M. Taniguchi, H. Ogiso, T. Takeuchi, K. Kitatani, H. Umehara, and T. Okazaki Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis Cell Death Dis. 6 2015 e1717
164. J.L.W. Thudichum, and D.L. Drabkin A Treatise on the Chemical Constitution of the Brain 1962 Hamden, Ct
165. J. Tibboel, I. Reiss, J.C. de Jongste, and M. Post Ceramides: a potential therapeutic target in pulmonary emphysema Respir. Res. 14 2013 96
166. S. Tomiuk, K. Hofmann, M. Nix, M. Zumbansen, and W. Stoffel Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling Proc. Natl. Acad. Sci. U. S. A. 95 1998 3638 3643
167. K. Trajkovic, C. Hsu, S. Chiantia, L. Rajendran, D. Wenzel, F. Wieland, P. Schwille, B. Brugger, and M. Simons Ceramide triggers budding of exosome vesicles into multivesicular endosomes Science 319 2008 1244 1247
168. J.P. Truman, M.M. Al Gadban, K.J. Smith, and S.M. Hammad Acid sphingomyelinase in macrophage biology Cell Mol. Life Sci. 68 2011 3293 3305
169. R. Uchida, H. Tomoda, Y. Dong, and S. Omura Alutenusin, a specific neutral sphingomyelinase inhibitor, produced by Penicillium sp. FO-7436 J. Antibiot. (Tokyo) 52 1999 572 574
170. A.M. Vacaru, J. van den Dikkenberg, P. Ternes, and J.C. Holthuis Ceramide phosphoethanolamine biosynthesis in Drosophila is mediated by a unique ethanolamine phosphotransferase in the Golgi lumen J. Biol. Chem. 288 2013 11520 11530
171. A.H. Van der Luit, M. Budde, S. Zerp, W. Caan, J.B. Klarenbeek, M. Verheij, and W.J. Van Blitterswijk Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts Biochem. J. 401 2007 541 549
172. A. van Helvoort, W. van't Hof, T. Ritsema, A. Sandra, and G. van Meer Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells. Evidence for the reverse action of a sphingomyelin synthase J. Biol. Chem. 269 1994 1763 1769
173. M. Villani, M. Subathra, Y.B. Im, Y. Choi, P. Signorelli, M. Del Poeta, and C. Luberto Sphingomyelin synthases regulate production of diacylglycerol at the Golgi Biochem. J. 414 2008 31 41
174. G. Wang, M. Dinkins, Q. He, G. Zhu, C. Poirier, A. Campbell, M. Mayer-Proschel, and E. Bieberich Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD) J. Biol. Chem. 287 2012 21384 21395
175. V. Wascholowski, A. Giannis, and E.N. Pitsinos Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase ChemMedChem 1 2006 718 721
176. M.D. White, L. Chan, J.W. Antoon, and B.S. Beckman Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640 Anticancer Res. 33 2013 3573 3579
177. M.L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P.W. Gold, E. Hirsch, K.J. Williams, J. Licinio, and I. Tabas Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis Proc. Natl. Acad. Sci. U. S. A. 97 2000 8681 8686
178. B.X. Wu, V. Rajagopalan, P.L. Roddy, C.J. Clarke, and Y.A. Hannun Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5 J. Biol. Chem. 285 2010 17993 18002
179. J. Wu, Y. Cheng, A. Nilsson, and R.D. Duan Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells Carcinogenesis 25 2004 1327 1333
180. T. Yabu, A. Shimuzu, and M. Yamashita A novel mitochondrial sphingomyelinase in zebrafish cells J. Biol. Chem. 284 2009 20349 20363
181. M. Yano, K. Watanabe, T. Yamamoto, K. Ikeda, T. Senokuchi, M. Lu, T. Kadomatsu, H. Tsukano, M. Ikawa, M. Okabe, S. Yamaoka, T. Okazaki, H. Umehara, T. Gotoh, W.J. Song, K. Node, R. Taguchi, K. Yamagata, and Y. Oike Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice J. Biol. Chem. 286 2011 3992 4002
182. M. Yano, T. Yamamoto, N. Nishimura, T. Gotoh, K. Watanabe, K. Ikeda, Y. Garan, R. Taguchi, K. Node, T. Okazaki, and Y. Oike Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice PLoS One 8 2013 e61380
183. J. Yeboah, C. McNamara, X.C. Jiang, I. Tabas, D.M. Herrington, G.L. Burke, and S. Shea Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis Arterioscler. Thromb. Vasc. Biol. 30 2010 628 633
184. Y. Yoshida, K. Arimoto, M. Sato, N. Sakuragawa, M. Arima, and E. Satoyoshi Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs J. Biochem. 98 1985 1669 1679
185. Y. Zhang, Y. Cheng, G.H. Hansen, L.L. Niels-Christiansen, F. Koentgen, L. Ohlsson, A. Nilsson, and R.D. Duan Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice J. Lipid Res. 52 2011 771 781
186. N.C. Zitomer, T. Mitchell, K.A. Voss, G.S. Bondy, S.T. Pruett, E.C. Garnier-Amblard, L.S. Liebeskind, H. Park, E. Wang, M.C. Sullards, A.H. Jr. Merrill, and R.T. Riley Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals J. Biol. Chem. 284 2009 4786 4795